The role of endothelium in the onset of antibody-mediated TRALI

Blood Rev. 2018 Jan;32(1):1-7. doi: 10.1016/j.blre.2017.08.003. Epub 2017 Aug 5.

Abstract

Transfusion Related Acute Lung Injury (TRALI) is one of the leading causes of mortality and morbidity following blood transfusion. The mechanisms behind the disease are not yet fully understood but seem to involve many different activating pathways and donor factors, in synergy with patient susceptibility. Studies have focused mostly on neutrophil activation, as aggregates of neutrophils and edema in lungs are found in post-mortem histological sections. This review aims to highlight the role of the endothelium in TRALI, as activated endothelium is the main promoter of leukocyte transmigration, and creates the barrier between blood and tissue. Since recent evidence suggests that a strong endothelial barrier prevents leukocyte transmigration and vascular leakage, we suggest that strengthening this barrier may be key to TRALI prevention.

Keywords: Antibodies; Cellular adhesion molecules; Endothelium; HLA; HNA; TRALI; Transendothelial migration.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies / adverse effects*
  • Antibodies / immunology
  • Antibodies / metabolism
  • Biomarkers
  • Cell Adhesion Molecules / metabolism
  • Disease Susceptibility
  • Endothelium / metabolism*
  • HLA Antigens / immunology
  • Humans
  • Leukocytes / immunology
  • Leukocytes / metabolism
  • Transendothelial and Transepithelial Migration
  • Transfusion-Related Acute Lung Injury / etiology*
  • Transfusion-Related Acute Lung Injury / metabolism*

Substances

  • Antibodies
  • Biomarkers
  • Cell Adhesion Molecules
  • HLA Antigens